References
1. Mac S, Shi S, Millson B, Tehrani A, Eberg M, Myageri V, et al. Burden of illness associated with Respiratory Syncytial Virus (RSV)-related hospitalizations among adults in Ontario, Canada: A retrospective population-based study. Vaccine. 7 de agosto de 2023;41(35):5141-9.
2. Fretzayas A, Moustaki M. Etiology and clinical features of viral bronchiolitis in infancy. World J Pediatr. agosto de 2017;13(4):293-9.
3. van Houten CB, Oved K, Eden E, Cohen A, Engelhard D, Boers S, et al. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the «TAILORED-Treatment» study. BMC Infect Dis. 7 de agosto de 2018;18(1):377.
4. Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. 10 de septiembre de 2019;366:l5021.
5. Coppée R, Chenane HR, Bridier-Nahmias A, Tcherakian C, Catherinot E, Collin G, Lebourgeois S, Visseaux B, Descamps D, Vasse M, Farfour E. Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021. Virus Res. 2022 Sep 29;323:198950. doi: 10.1016/j.virusres.2022.198950. Epub ahead of print. PMID: 36181977; PMCID: PMC9519364.
6. Ghazaly M, Nadel S. Characteristics of children admitted to intensive care with acute bronchiolitis. Eur J Pediatr. junio de 2018;177(6):913-20.
7. Meissner HC. More on Viral Bronchiolitis in Children. N Engl J Med. 22 de septiembre de 2016;375(12):1200.
8. Li T, Fang H, Liu X, Deng Y, Zang N, Xie J, et al. Defining RSV epidemic season in southwest China and assessing the relationship between birth month and RSV infection: A 10-year retrospective study from June 2009 to May 2019. J Med Virol. julio de 2023;95(7):e28928.
9. Hamid S, Winn A, Parikh R, Jones JM, McMorrow M, Prill MM, et al. Seasonality of Respiratory Syncytial Virus - United States, 2017-2023. MMWR Morb Mortal Wkly Rep. 7 de abril de 2023;72(14):355-61.
10. Chen G. Lan M, Lin S, Zhang Y, Zhang D, Weng Y, Zheng K. Genome analysis of human respiratory syncytial virus in Fujian Province, Southeast China. Infect Genet Evol. 2022 Sep;103:105329. doi: 10.1016/j.meegid.2022.105329. Epub 2022 Jul 3. PMID: 35788050.
11. Teirlinck AC. Broberg EK, Stuwitz Berg A, Campbell H, Reeves RM, Carnahan A, Lina B, Pakarna G, Bøås H, Nohynek H, Emborg HD, Nair H, Reiche J, Oliva JA, O’Gorman J, Paget J, Szymanski K, Danis K, Socan M, Gijon M, Rapp M,Havlíčková M , Trebbien R, Guiomar R, Hirve SS, Buda S, van der Werf S, Meijer A, Fischer TK. Recommendations for respiratory syncytial virus surveillance at the national level. Eur Respir J. 2021 Oct 1;58(3):2003766. doi: 10.1183/13993003.03766-2020. PMID: 33888523; PMCID: PMC8485062.
12. Staadegaard L. Caini S, Wangchuk S, Thapa B, de Almeida WAF, de Carvalho FC, Njouom R, Fasce RA, Bustos P, Kyncl J, Novakova L, Caicedo AB, de Mora Coloma DJ, Meijer A, Hooiveld M, Huang S, Wood T, Guiomar R, Rodrigues AP, Danilenko D, Stolyarov K, Lee VJM, Ang LW, Cohen C, Moyes J, Larrauri A, Delgado-Sanz C, Le MQ, Hoang PVM, Demont C, Bangert M, van Summeren J, Dückers M, Paget J. The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries. Open Forum Infect Dis. 2021 Mar 30;8(7):ofab159. doi: 10.1093/ofid/ofab159. PMID: 34337092; PMCID: PMC8320297.
13. Strine MS, Wilen CB. Game over for RSV? Sci Immunol. 8 de junio de 2023;8(84):eadi8764.
14. Simões EAF, Madhi SA, Muller WJ, Atanasova V, Bosheva M, Cabañas F, et al. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials. Lancet Child Adolesc Health. marzo de 2023;7(3):180-9.
15. Menasalvas Ruiz AI. Respiratory syncytial virus infection in COVID-19 times: Trick or threat? Enferm Infecc Microbiol Clin (Engl Ed). 2023;41(6):319-20.
16. Falsey AR, Walsh EE. Respiratory syncytial virus Prefusion F vaccine. Cell. 20 de julio de 2023;186(15):3137-3137.e1.
17. Nguyen-Van-Tam JS, O’Leary M, Martin ET, Heijnen E, Callendret B, Fleischhackl R, et al. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Eur Respir Rev. 31 de diciembre de 2022;31(166):220105.
18. Heppe-Montero M, Gil-Prieto R, Del Diego Salas J, Hernández-Barrera V, Gil-de-Miguel Á. Impact of Respiratory Syncytial Virus and Influenza Virus Infection in the Adult Population in Spain between 2012 and 2020. Int J Environ Res Public Health. 9 de noviembre de 2022;19(22):14680.
19. Ackerson B, Tseng HF, Sy LS, Solano Z, Slezak J, Luo Y, et al. Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults. Clin Infect Dis. 2 de julio de 2019;69(2):197-203.
20. Belongia EA, King JP, Kieke BA, Pluta J, Al-Hilli A, Meece JK, et al. Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old. Open Forum Infect Dis. diciembre de 2018;5(12):ofy316.
21. Gómez-Novo M, Boga JA, Álvarez-Argüelles ME, Rojo-Alba S, Fernández A, Menéndez MJ, et al. Human respiratory syncytial virus load normalized by cell quantification as predictor of acute respiratory tract infection. J Med Virol. mayo de 2018;90(5):861-6.
22. Agha R, Avner JR. Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic. Pediatrics. septiembre de 2021;148(3):e2021052089.
23. Hill-Ricciuti A, Walsh EE, Greendyke WG, Choi Y, Barrett A, Alba L, et al. Clinical impact of healthcare-associated respiratory syncytial virus in hospitalized adults. Infect Control Hosp Epidemiol. marzo de 2023;44(3):433-9.
24. Savic M, Penders Y, Shi T, Branche A, Pirçon JY. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis. Influenza Other Respir Viruses. enero de 2023;17(1):e13031.
25. Gilca R, De Serres G, Tremblay M, Vachon ML, Leblanc E, Bergeron MG, et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J Infect Dis. 1 de enero de 2006;193(1):54-8.
26. Robertson M. Eden JS, Levy A, Carter I, Tulloch RL, Cutmore EJ, Horsburgh BA, Sikazwe CT, Dwyer DE, Smith DW, Kok J. The spatial-temporal dynamics of respiratory syncytial virus infections across the east-west coasts of Australia during 2016-17. Virus Evol. 2021 Jul 22;7(2):veab068. doi: 10.1093/ve/veab068. PMID: 34532066; PMCID: PMC8438877.
27. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis. abril de 1991;163(4):693-8.
28. Ahani B, Tuffy KM, Aksyuk AA, Wilkins D, Abram ME, Dagan R, et al. Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials. Nat Commun. 19 de julio de 2023;14(1):4347.
29. Otieno JR. Kamau EM, Agoti CN, Lewa C, Otieno G, Bett A, et al. Spread and evolution of respiratory syncytial virus A genotype ON1, coastal Kenya, 2010-2015. Emerg Infect Dis. 2017;23:264–71.
30. Viegas M. Goya S, Mistchenko AS. Sixteen years of evolution of human respiratory syncytial virus subgroup A in Buenos Aires, Argentina: GA2 the prevalent genotype through the years. Infect Genet Evol. 2016;43:213–21.
31. Luo Q. Li M, Li A, Gong C, Dong M, Huang Q, Luo M, Zhang H, Huang F. Genetic diversity and epidemiological features of respiratory syncytial virus, Beijing, 2015-2019: A multicenter and all-age groups study. J Infect. 2022 Jul;85(1):75-85. doi: 10.1016/j.jinf.2022.04.046. Epub 2022 May 6. PMID: 35533834.
32. Lin TY. Chi H, Kuo CY, Tsai HP, Wang JR, Liu CC, Shen CF. Outbreak of respiratory syncytial virus subtype ON1 among children during COVID-19 pandemic in Southern Taiwan. J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 2):1168-1179. doi: 10.1016/j.jmii.2022.08.015. Epub 2022 Sep 13. PMID: 36137926.
33. Gaymard A,. Bouscambert-Duchamp M, Pichon M, Frobert E, Vallee J, Lina B, Casalegno JS, Morfin F. Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. J Clin Virol. 2018 May; 102:12-18. doi: 10.1016/j.jcv.2018.02.004. Epub 2018 Feb 6. PMID: 29471266.
34. Goya S, Sereewit J, Pfalmer D, Nguyen TV, Bakhash SAKM, Sobolik EB, et al. Genomic Characterization of Respiratory Syncytial Virus during 2022–23 Outbreak, Washington, USA - Volume 29, Number 4—April 2023 - Emerging Infectious Diseases journal - CDC. [citado 30 de agosto de 2023]; Disponible en: https://wwwnc.cdc.gov/eid/article/29/4/22-1834_article
35. Gimferrer L. Campins M, Codina MG, Martín Mdel C, Fuentes F, Esperalba J, Bruguera A, Vilca LM, Armadans L, Pumarola T, Antón A. Molecular epidemiology and molecular characterization of respiratory syncytial viruses at a tertiary care university hospital in Catalonia (Spain) during the 2013-2014 season. J Clin Virol. 2015 May;66:27-32. doi: 10.1016/j.jcv.2015.02.018. Epub 2015 Feb 26. PMID: 25866332.